Role of C-Reactive Protein /Albumin Ratio in Evaluation of Disease Activity in Patients With Inflammatory Bowel Disease
NCT05738915 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-02-22
Summary
Role of C-Reactive Protein /Albumin Ratio in evaluation of Disease Activity in Patients with Inflammatory Bowel Disease.
Conditions
- Inflammatory Bowel Diseases
Interventions
- DIAGNOSTIC_TEST
-
CRP/Albumin ratio in IBD
Role of C-Reactive Protein /Albumin Ratio in evaluation of Disease Activity in Patients with Inflammatory Bowel Disease.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-15
- Primary Completion
- 2023-07-15
- Completion
- 2023-08-15
More Related Trials
-
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
NCT06995170 ·Status: RECRUITING
-
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 ·Status: UNKNOWN ·Phase: PHASE4
-
Novel Biomarkers in Inflammatory Bowel Disease
NCT03833310 ·Status: COMPLETED
-
Role of Ultrasound in Inflammatory Bowel Disease
NCT05223452 ·Status: UNKNOWN
-
Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients
NCT06772350 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Platelet Indices in Inflammatory Bowel Diseases
NCT07320443 ·Status: NOT_YET_RECRUITING
-
Screening of Nutritional Status and Sarcopenia Among Patients With IBD
NCT05877209 ·Status: UNKNOWN
-
Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
NCT07343726 ·Status: NOT_YET_RECRUITING
-
Magnetic Resonance Enterography in Inflammatory Bowel Diseases
NCT04324632 ·Status: UNKNOWN
-
Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease
NCT04558658 ·Status: UNKNOWN
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704 ·Status: UNKNOWN ·Phase: NA
-
Value Of ACE Index (Albumin, CRP And Endoscopy) In Predicting Intra Venous Steroid Response In Acute Severe Ulcerative Colitis In Assiut University Hospitals
NCT06267651 ·Status: NOT_YET_RECRUITING
-
Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease
NCT00769236 ·Status: COMPLETED ·Phase: NA
-
The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative Colitis
NCT04670250 ·Status: UNKNOWN
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Association Between Vitamin D Deficiency and Inflammatory Bowel Disease
NCT07259603 ·Status: NOT_YET_RECRUITING
-
Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inflammatory Bowel Disease Patients
NCT06623383 ·Status: COMPLETED
-
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
NCT01666717 ·Status: COMPLETED
-
Response Assessment in SB CD
NCT03646708 ·Status: ACTIVE_NOT_RECRUITING
-
Exacerbating Factors in Inflammatory Bowel Disease
NCT01405105 ·Status: COMPLETED
-
Role of Multislice CT in Diagnosis of Inflammatory Bowel Disease
NCT03436966 ·Status: UNKNOWN
-
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788 ·Status: UNKNOWN
-
Quantitative Assessment of Intestinal Motility on Bowel Ultrasound in Patients With Inflammatory Bowel Disease: a Feasibility, Observational, Cross-sectional, Monocentric Study
NCT05719402 ·Status: UNKNOWN
-
Impact of Different Dietary IgGs on the Pathogenesis of IBD
NCT03885479 ·Status: UNKNOWN